罗哌卡因球结膜下注射治疗重症电光性眼炎  

Subconjunctival injection of Ropivacaine for the treatment of severe electric ophthalmitis

作　　者：冯冰冰 刘德成[2] 

机构地区：[1]开封市鼓楼医院眼科,河南475000 [2]郑州市第七人民医院眼科

出　　处：《中华眼外伤职业眼病杂志》2015年第10期781-783,共3页Chinese Journal of Ocular Trauma and Occupational Eye Disease

摘　　要：目的：1%罗哌卡因与0.9%氯化钠注射液等量混合球结膜下注射治疗重症电光性眼炎的临床效果。方法对32例（64眼）重症电光性眼炎行球结膜下注射罗哌卡因治疗,并观察其疗效。结果19例（38眼）,占58.75%的患者24 h内炎症消失,13例（26眼）,占41.25%的患者72 h内炎症消失,未出现并发症,均治愈。结论罗哌卡因为治疗重症电光性眼炎的有效方法,效果良好,应该加强健康宣教,注重个人防护,做好预防工作。Objective To observe the clinical effect of Ropivacaine hydrochloride subconjunctival injection for the treatment of severe electric ophthalmitis. Methods A total of 64 eyes of 32 cases of severe electric ophthalmitis were treated with subconjunctival injection of Ropivacaine hydrochloride. Results The symptom of inflammation disappeared within 24 h in 38 eyes of 19 cases, accounted for 58. 75%. The symptom disappeared within 72 h in 26 eyes of 13 cases, accounted for 41. 25%. There was no complication be found in any case. Conclusion Ropivacaine hydrochloride subconjunctival injection is effective for the treatment of severe electric ophthalmitis. The health education focusing on personal protection and preventive work should be strengthened.

关 键 词：电光性眼炎 重症 罗哌卡因 治疗 

分 类 号：R779.6[医药卫生—眼科]